May 02, 2025
Bulletin interne de l'Institut Pasteur
The antiviral drug tecovirimat is frequently used to treat mpox. But is it really effective, especially against the new, more pathogenic strain of the virus that has been in circulation since 2024? A study by the Institut Pasteur, recently published in The Lancet Infectious Diseases, concludes that it is.